Skip to main content Accessibility help

The marine biodiscovery pipeline and ocean medicines of tomorrow

  • Marcel Jaspars (a1), Donatella De Pascale (a2), Jeanette H. Andersen (a3), Fernando Reyes (a4), Alexander D. Crawford (a5) and Adrianna Ianora (a6)...


Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The marine biodiscovery pipeline and ocean medicines of tomorrow
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The marine biodiscovery pipeline and ocean medicines of tomorrow
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The marine biodiscovery pipeline and ocean medicines of tomorrow
      Available formats


Corresponding author

Correspondence should be addressed to:A. Ianora, Stazione Zoologica Anton Dohrn, Villa Comunale 80121, Naples, Italy email:


Hide All
Audoin, C., Bonhomme, D., Ivanisevic, J., de la Cruz, M., Cautain, B., Monteiro, M.C., Reyes, F., Rios, L., Perez, T. and Thomas, O. (2013) Balibalosides, an original family of glucosylated sesterterpenes produced by the Mediterranean sponge Oscarella balibaloi. Marine Drugs 11, 14771489.
Bérdy, J. (2012) Thoughts and facts about antibiotics: where we are now and where we are heading. Journal of Antibiotics (Tokyo) 65, 385395.
Blunt, J.W., Copp, B.R., Keyzers, R.A., Munro, M.H.G. and Prinsep, M.R. (2015) Marine natural products. Nature Product Report 32, 116211.
Cambon-Bonavita, M.A., Raguenes, G., Jean, J., Vincent, P. and Guezennec, J. (2002) A novel polymer produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. Journal of Applied Microbiology 93, 310315.
Cunliffe, V.T. (2015) Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures. Journal of Neuroscience Methods. doi: 10.1016/j.jneumeth.2015.07.015.
Daly, N.L. and Craik, D.J. (2011) Conopeptides as novel options for pain management. Drugs Future 36, 2532.
Dias, D.A., Urban, S. and Roessner, U. (2012) A historical overview of natural products in drug discovery. Metabolites 2, 303336.
European Marine Board (2013) Linking oceans and human health: a strategic research priority for Europe. Ostend: Position paper 19 of the European Marine Board.
Fiedor, J. and Burda, K. (2014) Potential role of carotenoids as antioxidants in human health and disease. Nutrients 6, 466488.
Gammone, M.A. and D'Orazio, N. (2015) Anti-obesity activity of the marine carotenoid fucoxanthin. Marine Drugs 13, 21962214.
Gerwick, W.H. and Moore, B.S. (2012) Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chemistry & Biology 19, 8598.
Glaser, K.B. and Mayer, A.M. (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochemical Pharmacology 78, 440448.
Hirata, Y. and Uemura, D. (1986) Halichondrins-antitumor polyether macrolides from a marine sponge. Pure and Applied Chemistry 58, 701710.
Jang, H.J., Nam, S.-J., Locke, J.B., Kauffman, C.A., Beatty, D.S., Paul, L.A. and Fenical, W. (2013) Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angewandte Chemie International Edition 52, 78227824.
Katz, J., Janik, J.E. and Younes, A. (2011) Brentuximab Vedotin (SGN-35). Clinical Cancer Research 17, 64286436.
Klotz, U. (2006) Ziconotide – a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain – a short review. International Journal of Clinical Pharmacology and Therapy 44, 478483.
Lacret, R., Oves-Costales, D., Gómez, C., Díaz, C., de la Cruz, M., Pérez-Victoria, I., Vicente, F., Genilloud, O. and Reyes, F. (2015) New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis. Marine Drugs 13, 128140.
Lallier, L.E., McMeel, O., Greiber, T., Vanagt, T., Dobson, A.D. and Jaspars, M. (2014) Access to and use of marine genetic resources: understanding the legal framework. Natural Product Report 31, 612616.
Larsson, D.G.K. (2014) Pollution from drug manufacturing: review and perspectives. Philosophical Transactions of the Royal Society B Biological Sciences 369, 20130571.
Leoutsakos, V. (2004) A short history of the thyroid gland. Hormones 3, 268271.
Lorente, A., Makowski, K., Albericio, F. and Álvarez, M. (2014) Bioactive marine polyketides as potential and promising drugs. Annals of Marine Biology and Research 1, 1003.
Martins, A., Vieira, H., Gaspar, H. and Santos, S. (2014) Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Marine Drugs 12, 10661101.
Mayer, A.M.S., Glaser, K.B., Cuevas, C., Jacobs, R.S., Kem, W., Little, R.D., McIntosh, J.M., Newman, D.J., Potts, B.C. and Shuster, D.E. (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharmacology Science 31, 255265.
Mayer, A.M.S., Rodríguez, A.D., Taglialatela-Scafati, O. and Fusetani, N. (2013) Marine pharmacology in 2009–2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Marine Drugs 11, 25102573.
Menis, J. and Twelves, C. (2011) Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer: Targets Therapy 3, 101111.
Mora, C., Tittensor, D.P., Adl, S., Simpson, A.G.B. and Worm, B. (2011) How many species are there on earth and in the ocean? PLoS Biol 9, e1001127.
Newman, D.J. and Cragg, G.M. (2014) Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Marine Drugs 12, 255278.
Potts, B.C., Albitar, M.X., Anderson, K.C., Baritaki, S., Berkers, C., Bonavida, B., Chandra, J., Chauhan, D., Cusack, J.C. Jr, Fenical, W., Ghobrial, I.M., Groll, M., Jensen, P.R., Lam, K.S., Lloyd, G.K., McBride, W., McConkey, D.J., Miller, C.P., Neuteboom, S.T., Oki, Y., Ovaa, H., Pajonk, F., Richardson, P.G., Roccaro, A.M., Sloss, C.M., Spear, M.A., Valashi, E., Younes, A. and Palladino, M.A. (2011) Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Current Cancer Drug Targets 11, 254284.
Rangel, M. and Falkenberg, A. (2015) An overview of the marine natural products in clinical trials and on the market. Journal of Coastal Life Medicine 3, 421428.
Rocha-Martin, J., Harrington, C., Dobson, A.D.W. and O'Gara, F. (2014) Emerging strategies and integrated systems microbiology technologies for biodiscovery of marine bioactive compounds. Marine Drugs 12, 35163559.
Sagar, S., Kaur, M. and Minneman, K.P. (2010) Antiviral lead compounds from marine sponges. Marine Drugs 8, 26192638.
Schoffski, P., Dumez, H., Wolter, P., Stefan, C., Wozniak, A., Jimeno, J. and Van Oosterom, A.T. (2008) Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opinion on Pharmacotherapy 9, 16091618.
Torjesen, I. (2015) Drug development: the journey of a medicine from lab to shelf. Pharmaceutical Journal.
VanHook, A.M. (2010) Behavioural fingerprinting. Science Signaling 10, 3, pp. ec22.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the Marine Biological Association of the United Kingdom
  • ISSN: 0025-3154
  • EISSN: 1469-7769
  • URL: /core/journals/journal-of-the-marine-biological-association-of-the-united-kingdom
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed